Literature DB >> 19902567

Tailoring cancer therapy - validating basic science with the 'supertrial'.

.   

Abstract

A paradigm shift in research culture is needed in order to set up the large ambitious trials needed to make personalised medicine a reality. Emma Wilkinson talks to the experts about the hurdles they face and what needs to change.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902567      PMCID: PMC5527542          DOI: 10.1016/j.molonc.2009.08.001

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  2 in total

1.  Turning the Stockholm Declaration into reality: Creating a world-class infrastructure for cancer research in Europe.

Authors:  Hannah Brown
Journal:  Mol Oncol       Date:  2008-11-17       Impact factor: 6.603

2.  The MINDACT trial: the first prospective clinical validation of a genomic tool.

Authors:  Fatima Cardoso; Martine Piccart-Gebhart; Laura Van't Veer; Emiel Rutgers
Journal:  Mol Oncol       Date:  2007-10-22       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.